Showing results (21-30 of 707) with videos related to

Sort By:
Pageof 71
Drug Design, Development and Therapy|August 9, 2018
Inotuzumab ozogamicin: a CD22 mAb-drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemiaIlana R Yurkiewicz, Lori Muffly, Michaela Liedtke
Leukemia & Lymphoma|February 7, 2013
A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemiaSamit Patel, Michaela Liedtke, Dat Ngo, et al.
JACC. Cardiooncology|November 29, 2022
AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art ReviewAshutosh D Wechalekar, Marianna Fontana, C Cristina Quarta, et al.
Cell Stem Cell|September 22, 2015
CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid LeukemiaMasayuki Iwasaki, Michaela Liedtke, Andrew J Gentles, et al.
Journal of Adolescent and Young Adult Oncology|June 21, 2018
Effect of Fitbit and iPad Wearable Technology in Health-Related Quality of Life in Adolescent and Young Adult Cancer PatientsIlana R Yurkiewicz, Pamela Simon, Michaela Liedtke, et al.
Cancer Immunology Research|August 4, 2017
Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone MarrowLeo Hansmann, Arnold Han, Livius Penter, et al.
Leukemia Research Reports|October 5, 2017
Diagnostic and therapeutic implications of genetic heterogeneity in myeloid neoplasms uncovered by comprehensive mutational analysisSarah M Choi, Ben Goldenson, Lo Ann Peterson, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2012
Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment optionsTamara Dunn, May Cho, Bruno Medeiros, et al.
Immunologic Research|February 14, 2014
Effects of serum and plasma matrices on multiplex immunoassaysYael Rosenberg-Hasson, Leo Hansmann, Michaela Liedtke, et al.
Bone Marrow Transplantation|April 7, 2021
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world dataTalha Badar, Aniko Szabo, Mark Litzow, et al.
Pageof 71